1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ZYDUS LIFESCIENCES LTD.
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE | BSE: 532321

Zydus Lifesciences Ltd. Live Share Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Founded in 1952, Zydus Lifesciences (formerly Cadila Healthcare) is a global pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of healthcare therapies. Its portfolio includes generics, branded generics, biosim...

Read More
1047.85 14.05 (1.36%)
31.81% Gain from 52W Low
1.0M
NSE+BSE Volume

NSE 18 Sep, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
60.0 / 100
Valuation Score
Mid Valuation
41.8 / 100
Momentum Score
Technically Moderately Bullish
64.5 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
1,012
1Yr Price target downside is -3%
30 analysts

28

S

2

W

4

O

4

T

SWOT Analysis

Zydus Lifesciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
Is Cadila Healthcare Ltd. worth buying?
859 Votes:
Buy 81.84%
Sell 9.9%
Hold 8.27%
BUY
SELL
HOLD